The Buzz Around Methylene Blue: Separating Fact From Fiction
There has been a surge of interest in methylene blue, a liquid chemical that is now being marketed as a health supplement. Online platforms are abuzz with claims that methylene blue is a nootropic agent, capable of enhancing cognitive function, improving memory, boosting focus, and dispelling brain fog. Influencers like podcaster Joe Rogan and Robert F. Kennedy Jr. have sung its praises, sparking curiosity and excitement among consumers.
As a researcher specializing in inflammation and cancer, I have delved into the world of synthetic dyes and their impact on human health. While the allure of methylene blue’s purported benefits is undeniable, the evidence supporting its health claims remains scarce, and there are significant risks associated with its use outside of medical supervision.

Understanding Methylene Blue
Originally developed in 1876 as a textile dye, methylene blue has since found its way into the realm of medicine. While it shares similarities with commonly used food dyes, it is not derived from petroleum and is considered to be free from associated health risks. With its origins in staining biological tissues and combating malaria parasites, methylene blue has a rich history in both the textile and medical industries.
Its unique chemical properties allow it to interact with other molecules, serving purposes such as testing milk contamination and restoring hemoglobin function in cases of methemoglobinemia. Additionally, methylene blue is utilized in various medical applications, from treating carbon monoxide poisoning to highlighting specific tissues during surgical procedures.
The Role of Methylene Blue in Brain Health
Recent research suggests that methylene blue can penetrate the blood-brain barrier and support mitochondrial function, aiding in cellular energy production. Studies in animal models have indicated potential benefits in learning enhancement, memory improvement, and brain cell protection, particularly in conditions like Alzheimer’s disease and stroke.
While preliminary findings in humans have shown promising results in memory enhancement and brain activity modulation, larger clinical trials are needed to validate these effects and determine the optimal dosage and long-term safety of methylene blue supplementation.
Assessing Safety Concerns
While methylene blue is generally considered safe under medical supervision, it carries risks when used inappropriately. Interactions with common medications, potential side effects like serotonin syndrome, and adverse effects in individuals with certain genetic deficiencies underscore the importance of cautious and informed usage.
As researchers continue to explore the potential benefits of methylene blue in various health conditions, the need for robust clinical trials and comprehensive safety assessments remains imperative to ensure its efficacy and minimize potential harm.
Lorne J. Hofseth, Professor and Associate Dean for Research, College of Pharmacy, University of South Carolina
This article is republished from The Conversation under a Creative Commons license. Read the original article here.